Ns 2/3 cleavage site-derived peptide 17

Structural Information

Molecular Formula

C₇₄H₁₁₃N₁₉O₂₁

SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N

InChI

InChI=1S/C74H113N19O21/c1-10-38(6)59(70(110)92-60(41(9)95)71(111)82-39(7)61(101)87-52(31-42-19-21-44(96)22-20-42)67(107)90-54(35-94)73(113)114)91-69(109)55-18-14-28-93(55)72(112)40(8)83-65(105)50(29-36(2)3)89-66(106)51(30-37(4)5)88-64(104)48(17-13-27-79-74(77)78)86-68(108)53(32-43-33-80-47-16-12-11-15-45(43)47)84-57(98)34-81-63(103)49(24-25-56(76)97)85-62(102)46(75)23-26-58(99)100/h11-12,15-16,19-22,33,36-41,46,48-55,59-60,80,94-96H,10,13-14,17-18,23-32,34-35,75H2,1-9H3,(H2,76,97)(H,81,103)(H,82,111)(H,83,105)(H,84,98)(H,85,102)(H,86,108)(H,87,101)(H,88,104)(H,89,106)(H,90,107)(H,91,109)(H,92,110)(H,99,100)(H,113,114)(H4,77,78,79)/t38-,39-,40-,41+,46-,48-,49-,50-,51-,52-,53-,54-,55-,59-,60-/m0/s1

InChIKey

RKXULTYBODMBAD-LSYGAMDLSA-N

Compound name

(4S)-4-amino-5-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxopentanoic acid

Related CIDs

• CID 25078061